LOS ANGELES, Nov. 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global deve
Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
DeepHealth commercializes remote-imaging offering featuring TechLive™ remote scanning and Alpha RT's MRI staffing services, training and safety software.
LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of di
Harbor Capital sold over 300,000 RadNet shares, worth around $19.74 million. The trade was worth about 1.53% of Harbor Capital's 13F AUM.
Amid earnings buzz, stocks like RadNet, Mission Produce, Castle Biosciences and FreightCar America stand out for their rising cash flows and resilience.
Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagno
LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of outpatient imag
LOS ANGELES, Sept. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an
RadNet, Inc. (NASDAQ:RDNT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:50 PM EDT Company Participants Howard Berger - Chairman, President & CEO Mark Stolper - Executiv
LOS ANGELES, Sept. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an
Investors worried about missing the boat on overvalued stocks need not fret. These five names, while expensive, are still seeing lots of love from analysts.
RadNet, Inc. (NASDAQ:RDNT ) Q2 2025 Earnings Conference Call August 11, 2025 10:30 AM ET Company Participants Howard G. Berger - Chairman, President & CEO Mark D.
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to
LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a net
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE